Kewaunee Scientific (KEQU) Stock Price, News & Analysis

Company Overview

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Key Stats

• Today's Range: $38.08 to $39.79
• 50-Day Range: $31.31 to $41.40
• 52-Week Range: $30.33 to $71.33
• Volume: 2,914 shs
• Average Volume: 23,740 shs
• Market Capitalization: $111.94 million
• P/E Ratio: 6.21
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KEQU Stock Analysis - Frequently Asked Questions

How have KEQU shares performed this year?

Kewaunee Scientific's stock was trading at $61.87 on January 1st, 2025. Since then, KEQU shares have decreased by 36.6% and is now trading at $39.21.
View the best growth stocks for 2025 here.

How were Kewaunee Scientific's earnings last quarter?

Kewaunee Scientific Co. (NASDAQ:KEQU) announced its quarterly earnings data on Wednesday, March, 12th. The technology company reported $1.09 EPS for the quarter. The technology company had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a trailing twelve-month return on equity of 25.83%.

Who are Kewaunee Scientific's major shareholders?

Kewaunee Scientific's top institutional investors include Northern Trust Corp (9.55%), Minerva Advisors LLC (2.58%), Minerva Advisors LLC (2.58%) and American Century Companies Inc. (1.72%). Insiders that own company stock include Thomas David Hull III, John Russell, Keith M Gehl, Donald T Gardner III, Elizabeth D Phillips, Ryan S Noble and Douglas J Batdorff.
View institutional ownership trends.

How do I buy shares of Kewaunee Scientific?

Shares of KEQU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Kewaunee Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kewaunee Scientific investors own include Broadcom (AVGO), NVIDIA (NVDA), e.l.f. Beauty (ELF), Jabil (JBL), Arista Networks (ANET), Adobe (ADBE) and Disc Medicine (IRON).

Company Calendar

• Last Earnings: 3/12/2025
• Today: 6/06/2025
• Next Earnings (Estimated): 6/25/2025
• Fiscal Year End: 4/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Laboratory apparatus & furniture
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:KEQU
• CIK: 55529
• Web: www.kewaunee.com
• Phone: (704) 873-7202
• Fax: 704-873-5160
• Employees: 890
• Year Founded: 1906

Profitability

• EPS (Most Recent Fiscal Year): $5.91
• Trailing P/E Ratio: 6.21
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $18.75 million
• Net Margins: 9.39%
• Pretax Margin: N/A
• Return on Equity: 25.83%
• Return on Assets: 10.75%

Debt

• Debt-to-Equity Ratio: 0.45
• Current Ratio: 2.64
• Quick Ratio: 2.13

Sales & Book Value

• Annual Sales: $220.03 million
• Price / Sales: 0.51
• Cash Flow: $0.87 per share
• Price / Cash Flow: 45.30
• Book Value: $13.60 per share
• Price / Book: 2.88

Miscellaneous

• Outstanding Shares: 2,855,000
• Free Float: 2,464,000
• Market Cap: $111.94 million
• Optionable: Not Optionable
• Beta: 0.56